|
|
 | | | |
- close
- close
- close
- close
| |||||||||
This excerpt taken from the UNH 10-K filed Feb 11, 2009. 14. Fair Value of Financial Instruments In the normal course of business, the Company invests in various financial assets, incur various financial liabilities and enter into agreements involving derivative securities. Fair values are disclosed for all financial instruments for which it is practicable to estimate fair value, whether or not such values are recognized in the Consolidated Balance Sheets. Management obtains quoted market prices for these disclosures. The carrying amounts reported in the Consolidated Balance Sheets for cash and cash equivalents, premium and other current receivables, unearned premiums, accounts payable and accrued expenses, income taxes payable, and certain other current liabilities approximate fair value because of their short-term nature. For a discussion of the methods and assumptions that were used to estimate the fair value of each class of financial instrument see Note 5 to the Notes to Consolidated Financial Statements for information on Debt and Equity Securities, Note 13 to the Notes to Consolidated Financial Statements for information on AARP and Note 9 to the Notes to Consolidated Financial Statements for information related to Interest Rate Swaps and Senior Unsecured Notes. The carrying values and fair values of the Company’s financial instruments at December 31 are as follows:
85
Table of ContentsUNITEDHEALTH GROUP NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
This excerpt taken from the UNH 10-K filed Feb 21, 2008. Fair Value of Financial Instruments In the normal course of business, we invest in various financial assets, incur various financial liabilities and enter into agreements involving derivative securities. Fair values are disclosed for all financial instruments for which it is practicable to estimate fair value, whether or not such values are recognized in the Consolidated Balance Sheets. Management obtains quoted market prices for these disclosures. The carrying amounts reported in the Consolidated Balance Sheets for cash and cash equivalents, premium and other receivables, unearned premiums, accounts payable and accrued expenses, income taxes payable, and certain other current liabilities approximate fair value because of their short-term nature. The following methods and assumptions were used to estimate the fair value of each class of financial instrument:
This excerpt taken from the UNH 10-K filed Mar 6, 2007. Fair Value of Financial Instruments In the normal course of business, we invest in various financial assets, incur various financial liabilities and enter into agreements involving derivative securities. Fair values are disclosed for all financial instruments for which it is practicable to estimate fair value, whether or not such values are recognized in the Consolidated Balance Sheets. Where available, management obtains quoted market prices for these disclosures; otherwise, fair values are estimated using valuation techniques. The carrying amounts reported in the Consolidated Balance Sheets for cash and cash equivalents, premium and other receivables, unearned premiums, accounts payable and accrued expenses, income taxes payable, and certain other current liabilities approximate fair value because of their short-term nature. The following methods and assumptions were used to estimate the fair value of each class of financial instrument:
| EXCERPTS ON THIS PAGE:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||
